Navigation Links
Cerimon Pharmaceuticals Appoints James S. Shannon, M.D., to Board of Directors
Date:12/2/2008

is a biopharmaceutical company dedicated to developing and commercializing therapeutic products for pain and inflammation. The Company's lead product, its topical diclofenac patch, recently reported positive Phase II results and plans to initiate the patch Phase III development program in 1Q 2009. Cerimon is financed by the premier investors, MPM, Normura Phase4 and OrbiMed Advisors.

For more information on Cerimon, please visit the Company's website at http://www.cerimon.com.


'/>"/>
SOURCE Cerimon Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cerimon Pharmaceuticals Names Matthew J. Meyer its General Counsel and Vice President of Business Development and Licensing
2. Cerimon Pharmaceuticals to Present at the 2007 BIO Investor Forum
3. Webcast Alert: Regulus Therapeutics, Alnylam Pharmaceuticals and Isis Pharmaceuticals Announce New Nature Publication on miR-21 Conference Call
4. Cell Therapeutics, Inc. (CTI) to Discuss Zevalin Joint Venture with Spectrum Pharmaceuticals
5. Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug
6. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
7. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
8. Celator(R) Pharmaceuticals to Present at Piper Jaffray Health Care Conference and Mid-Atlantic Capital Conference
9. Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results
10. Poniard Pharmaceuticals Announces Commercial Supply Agreement for Picoplatin
11. WWMR Announces Pain Clinic Physicians Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):First-in-class treatment for acute leukemia 2First-in-class treatment for acute leukemia 3Study finds new relationship between gene duplication and alternative splicing in plants 2Study finds new relationship between gene duplication and alternative splicing in plants 3Researchers demonstrate nanoscale X-ray imaging of bacterial cells 2Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 16 2009 14777 1Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 16 2009 14777 2PLC Systems Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6134 1PLC Systems Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6134 2PLC Systems Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6134 3Reportlinker Adds The Prescribing Data Restriction Program 3A Critical Assessment and Best Practices 6128 1Reportlinker Adds The Prescribing Data Restriction Program 3A Critical Assessment and Best Practices 6128 2Reportlinker Adds The Prescribing Data Restriction Program 3A Critical Assessment and Best Practices 6128 3Reportlinker Adds The Prescribing Data Restriction Program 3A Critical Assessment and Best Practices 6128 4Reportlinker Adds The Prescribing Data Restriction Program 3A Critical Assessment and Best Practices 6128 5Reportlinker Adds The Prescribing Data Restriction Program 3A Critical Assessment and Best Practices 6128 6Reportlinker Adds The Prescribing Data Restriction Program 3A Critical Assessment and Best Practices 6128 7Reportlinker Adds The Prescribing Data Restriction Program 3A Critical Assessment and Best Practices 6128 8Reportlinker Adds The Prescribing Data Restriction Program 3A Critical Assessment and Best Practices 6128 9Reportlinker Adds The Prescribing Data Restriction Program 3A Critical Assessment and Best Practices 6128 10Reportlinker Adds The Prescribing Data Restriction Program 3A Critical Assessment and Best Practices 6128 11Reportlinker Adds The Prescribing Data Restriction Program 3A Critical Assessment and Best Practices 6128 12Reportlinker Adds The Prescribing Data Restriction Program 3A Critical Assessment and Best Practices 6128 13Reportlinker Adds The Prescribing Data Restriction Program 3A Critical Assessment and Best Practices 6128 14Reportlinker Adds The Prescribing Data Restriction Program 3A Critical Assessment and Best Practices 6128 15Reportlinker Adds The Prescribing Data Restriction Program 3A Critical Assessment and Best Practices 6128 16Reportlinker Adds The Prescribing Data Restriction Program 3A Critical Assessment and Best Practices 6128 17Reportlinker Adds The Prescribing Data Restriction Program 3A Critical Assessment and Best Practices 6128 18Reportlinker Adds The Prescribing Data Restriction Program 3A Critical Assessment and Best Practices 6128 19